ALS Association Awards Neuropore $500K to Advance Potential Anti-inflammatory Therapy
Neuropore Therapies was awarded a $500,000 grant from The ALS Association to advance in preclinical work its neural protective…
Articles by Catarina Silva
Bloom Science Granted Exclusive Option to License Gut Microbiome-based Therapies for ALS, Other Neurological Disorders
Bloom Science and Duke University have entered into an exclusive licensing agreement that provides the biopharmaceutical company access…
AI-based Platform Suggests Cancer Candidate LAM-002 as Possible ALS Therapy, AI Therapeutics Says
AI Therapeutics‘ lymphoma candidate LAM-002 was identified by the company’s artificial intelligence-based platform — called Guardian…
Potential Oral Treatment for Cell Energy in ALS to Enter Phase 1 Trial, Stealth Bio Announces
Stealth BioTherapeutics announced the initiation of a Phase 1 trial to assess the safety and tolerability of its investigational oral…
Dosing Begins in Phase 2 Study of Nanomedicine as Disease-modifying ALS Treatment
A first patient has been dosed in a Phase 2 trial testing a nanomedicine called CNM-Au8 as a potentially disease-modifying therapy…
Neuropore’s Potential ALS Oral Treatment Found to be Safe and Well-Tolerated in Healthy Volunteers, Phase 1 Trial Shows
A recently completed Phase 1 trial studying NPT520-34 — an investigational small molecule being developed by Neuropore Therapies…
Compound in Rice Bran Oil Protects Nerve Cells in ALS Models, Study Finds
A compound found in rice bran oil may lower oxidative stress levels and may be beneficial to people with amyotrophic…
How Common ALS Mutation Damages Cells and Leads to Toxic Protein Being Produced Detailed in Study
The most common genetic cause of amyotrophic lateral sclerosis (ALS) disrupts the shape and workings of a compartment inside…
Variations of TP73 Gene Contribute to ALS Disease Mechanism, Study Suggests
People with mutations in the gene coding for tumor protein p73 (TP73) are at higher risk of developing amyotrophic…
Elevated Levels of ‘Bad Cholesterol’ May Be Risk Factor for ALS, Study Reports
High LDL cholesterol levels, also known as “bad cholesterol,” may contribute to the development of amyotrophic lateral sclerosis (ALS),…